IRTCiRhythm Technologies, Inc.

Nasdaq irhythmtech.com


$ 71.54 $ -2.19 (-2.97 %)    

Tuesday, 17-Sep-2024 15:59:59 EDT
QQQ $ 473.83 $ 0.25 (0.05 %)
DIA $ 417.12 $ -0.12 (-0.03 %)
SPY $ 563.14 $ 0.23 (0.04 %)
TLT $ 100.82 $ -0.49 (-0.48 %)
GLD $ 237.35 $ -1.32 (-0.55 %)
$ 71.51
$ 71.50 x 100
-- x --
-- - --
$ 60.88 - $ 124.12
354,888
na
2.23B
$ 1.30
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-01-2024 06-30-2024 10-Q
2 05-02-2024 03-31-2024 10-Q
3 02-22-2024 12-31-2023 10-K
4 11-02-2023 09-30-2023 10-Q
5 08-04-2023 06-30-2023 10-Q
6 05-04-2023 03-31-2023 10-Q
7 02-23-2023 12-31-2022 10-K
8 11-04-2022 09-30-2022 10-Q
9 08-05-2022 06-30-2022 10-Q
10 05-06-2022 03-31-2022 10-Q
11 02-28-2022 12-31-2021 10-K
12 11-05-2021 09-30-2021 10-Q
13 08-09-2021 06-30-2021 10-Q
14 05-10-2021 03-31-2021 10-Q
15 02-26-2021 12-31-2020 10-K
16 11-06-2020 09-30-2020 10-Q
17 08-07-2020 06-30-2020 10-Q
18 05-08-2020 03-31-2020 10-Q
19 03-02-2020 12-31-2019 10-K
20 12-23-2019 09-30-2019 10-Q
21 08-06-2019 06-30-2019 10-Q
22 05-10-2019 03-31-2019 10-Q
23 03-04-2019 12-31-2018 10-K
24 10-30-2018 09-30-2018 10-Q
25 08-03-2018 06-30-2018 10-Q
26 05-10-2018 03-31-2018 10-Q
27 03-01-2018 12-31-2017 10-K
28 11-14-2017 09-30-2017 10-Q
29 08-07-2017 06-30-2017 10-Q
30 05-12-2017 03-31-2017 10-Q
31 03-31-2017 12-31-2016 10-K
32 12-05-2016 09-30-2016 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 irhythm-teams-up-with-biointellisense-expanding-ambulatory-cardiac-monitoring-capabilities

iRhythm Technologies, Inc. (NASDAQ:IRTC), a leading digital health care company focused on creating trusted solutions that dete...

 reported-earlier-irhythms-guard-af-trial-highlights-zio-xt-patch-for-af-screening-in-older-adults-esc-presentation

iRhythm Technologies, Inc. (NASDAQ:IRTC), a leading digital health care company focused on creating trusted solutions that dete...

 citigroup-maintains-buy-on-irhythm-technologies-lowers-price-target-to-110

Citigroup analyst Joanne Wuensch maintains iRhythm Technologies (NASDAQ:IRTC) with a Buy and lowers the price target from $1...

 jp-morgan-maintains-overweight-on-irhythm-technologies-lowers-price-target-to-100

JP Morgan analyst Allen Gong maintains iRhythm Technologies (NASDAQ:IRTC) with a Overweight and lowers the price target from...

 oppenheimer-maintains-outperform-on-irhythm-technologies-lowers-price-target-to-145

Oppenheimer analyst Suraj Kalia maintains iRhythm Technologies (NASDAQ:IRTC) with a Outperform and lowers the price target f...

 baird-maintains-outperform-on-irhythm-technologies-lowers-price-target-to-110

Baird analyst Mike Polark maintains iRhythm Technologies (NASDAQ:IRTC) with a Outperform and lowers the price target from $1...

 truist-securities-reiterates-buy-on-irhythm-technologies-lowers-price-target-to-117

Truist Securities analyst Richard Newitter reiterates iRhythm Technologies (NASDAQ:IRTC) with a Buy and lowers the price tar...

 needham-maintains-buy-on-irhythm-technologies-lowers-price-target-to-119

Needham analyst David Saxon maintains iRhythm Technologies (NASDAQ:IRTC) with a Buy and lowers the price target from $138 to...

 irhythm-technologies-announces-brice-bobzien-cfo-will-step-down-for-personal-reasons-effective-august-31-2024-to-be-succeeded-by-daniel-wilson

iRhythm Technologies, Inc. (NASDAQ:IRTC), a leading digital health care company focused on creating trusted solutions that dete...

 irhythm-technologies-q2-2024-adj-eps-061-beats-089-estimate-sales-148000m-beat-146206m-estimate

iRhythm Technologies (NASDAQ:IRTC) reported quarterly losses of $(0.61) per share which beat the analyst consensus estimate of ...

 truist-securities-maintains-buy-on-irhythm-technologies-lowers-price-target-to-134

Truist Securities analyst David Rescott maintains iRhythm Technologies (NASDAQ:IRTC) with a Buy and lowers the price target ...

 morgan-stanley-maintains-overweight-on-irhythm-technologies-lowers-price-target-to-130

Morgan Stanley analyst Cecilia Furlong maintains iRhythm Technologies (NASDAQ:IRTC) with a Overweight and lowers the price t...

 chinas-bilibili-and-ollies-bargain-outlet-were-among-10-mid-cap-stocks-with-biggest-gains-in-the-last-week-june-16-june-22-2024-are-they-in-your-portfolio

Top performing mid-cap stocks last week: BILI (+23%), IBRX (+22%), SSL (+20%), OLLI (+15%), ITCI (+13%), AMKR (+12%), IRTC (+11...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION